In a new study, researchers identified the most common characteristics of 85 COVID-19 patients who died in Wuhan, China in the early stages of the coronavirus pandemic. The study reports on commonalities of the largest group ...
Apr 4, 2020
0
335
A new UCL and UCLH-led study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination, provides a clearer guide for clinicians trying to diagnose and treat patients.
Aug 9, 2021
2
1380
Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries.
Jan 20, 2017
0
14
A recent preclinical study from scientists at Sunnybrook Research Institute, Canadian Blood Services and the University of Toronto has demonstrated that focused ultrasound improves the delivery of intravenous immunoglobulin ...
Dec 8, 2020
0
118
A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known ...
Sep 2, 2011
0
0
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
For immunosuppressed patients, mRNA-1273 induces a stronger seroresponse than BNT162b2, according to a research letter published online May 16 in JAMA Network Open.
May 16, 2022
0
3
(HealthDay)—In a report published online Nov. 8 in Pediatrics, authors present the case of recurrent immune thrombocytopenia (ITP) after influenza vaccination.
Nov 9, 2016
0
1
Johns Hopkins Medicine researchers have shown that it is possible for solid organ transplant recipients who contract COVID-19 to experience a natural immune response to SARS-CoV-2, the virus that causes the disease. In their ...
Feb 10, 2021
0
4
New research in Blood Cancer Discovery shows that intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing treatment with an anti-BCMA bispecific antibody.
Sep 28, 2023
0
14
